Vertex Pharmaceuticals is set to launch its cystic fibrosis drug KALYDECO (ivacaftor) in New Zealand, which will be available to eligible patients from next month. The US biopharma company said…
ImmunoPrecise Antibodies has launched a coronavirus vaccine development program to address the new coronavirus originating in Wuhan, China apart from developing coronavirus-neutralizing antibodies for addressing prophylactic and therapeutic measures to…
Trulicity FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Trulicity (dulaglutide) to reduce major cardiovascular events (MACE) in…
PADCEV, KEYTRUDA combination : Astellas Pharma and Seattle Genetics said that the combination of PADCEV (enfortumab vedotin-ejfv) and Merck’s anti-PD-1 therapy KEYTRUDA (pembrolizumab) has been given breakthrough therapy designation from…
Upsher-Smith Laboratories has launched three new products – Fluvoxamine Maleate Tablets, Clonidine Hydrochloride Extended-Release Tablets, and Haloperidol Tablets, USP, to expand its generic portfolio. According to the US pharma company,…
Chinese CDMO WuXi Vaccines has signed a 20-year contract worth around $3bn with an undisclosed vaccine company to use a dedicated vaccine manufacturing facility in Ireland to supply commercial vaccine…
Australian clinical diagnostics company SpeeDx raises $15m in Series B round
SpeeDx, an Australian clinical diagnostics company, to support improved patient outcomes, has secured $15 million in a Series B funding round from US-based investor Northpond Ventures. The company…
Olympus secures FDA clearance for TJF-Q190V duodenoscope
Olympus Medical Systems Group has secured clearance from the US Food and Drug Administration (FDA) for its TJF-Q190V duodenoscope with a sterile, disposable distal endcap. The latest generation…
CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB
CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the removal of anti-platelet agent ticagrelor during surgery requiring cardiopulmonary bypass…
Novel coronavirus diagnostic test CoPrimer launched by Co-Diagnostics
Novel coronavirus diagnostic test : Co-Diagnostics, a US molecular diagnostics company, said that its research use only (RUO) CoPrimer test for the 2019-nCoV coronavirus is ready for sale…
Cystic fibrosis drug KALYDECO to be launched in New Zealand by Vertex Pharmaceuticals
Vertex Pharmaceuticals is set to launch its cystic fibrosis drug KALYDECO (ivacaftor) in New Zealand,…
ImmunoPrecise Antibodies launches vaccine development program for COVID-19
ImmunoPrecise Antibodies has launched a coronavirus vaccine development program to address the new coronavirus originating…
Upsher-Smith Laboratories launches three generic drugs in US
Upsher-Smith Laboratories has launched three new products – Fluvoxamine Maleate Tablets, Clonidine Hydrochloride Extended-Release Tablets,…
WuXi vaccine manufacturing facility in Ireland gets $3bn contract
Chinese CDMO WuXi Vaccines has signed a 20-year contract worth around $3bn with an undisclosed…
ALX Oncology raises $105m to advance clinical development of ALX148
ALX Oncology, a clinical-stage immuno-oncology company based in California, has raised $105 million in a…
Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer
Pinpoint Therapeutics, a US biopharma company focused on developing autophagy inhibitors for cancer treatment, has…
PCI acquires Canadian pharma packaging company Bellwyck Pharma Services
PCI Pharma Services, a pharma supply chain solutions provider, has acquired Canada-based pharma packaging company…
Latest Pharma News
-
Cystic fibrosis drug KALYDECO to be launched in New Zealand by Vertex Pharmaceuticals
-
ImmunoPrecise Antibodies launches vaccine development program for COVID-19
-
Lilly bags Trulicity FDA approval for reducing CV risk in type 2 diabetes patients
-
PADCEV, KEYTRUDA combination for advanced bladder cancer gets FDA breakthrough therapy status
-
Upsher-Smith Laboratories launches three generic drugs in US
-
WuXi vaccine manufacturing facility in Ireland gets $3bn contract
-
Reneo Pharmaceuticals launches REN001 clinical trial in McArdle disease
-
KIK-AS clinical trial : Angelman syndrome drug candidate GTX-102 to be evaluated by GeneTx Biotherapeutics
-
Epizyme gets FDA priority review for TAZVERIK in follicular lymphoma
-
ALX Oncology raises $105m to advance clinical development of ALX148
